logo
EU removes UAE from ‘high-risk' money-laundering list

EU removes UAE from ‘high-risk' money-laundering list

The National09-07-2025
The EU has removed the UAE from its list of countries that pose a high risk for money laundering and terrorist financing amid a drive in the Emirates to boost its regulatory framework.
The European Parliament voted not to object to the European Commission's proposal to amend the EU list of high-risk countries, enabling the removal of the UAE.
The Financial Action Task Force, the global body that combats money laundering and terrorism financing, removed the UAE from its 'grey list' in February last year after significant progress on reforms. The Emirates was placed on that list in 2022.
UAE Minister of State Ahmed Al Sayegh said the decision is "independent recognition" of the UAE's commitment to the highest international standards in combating global financial crime.
"The UAE remains a reliable and strategic partner to the EU, committed to ensuring AML/CFT systems are not only robust, but also future-proof and capable of addressing emerging global threats. As one of the world's fastest growing economies and as a trusted global financial hub, the UAE will continue working with all our global partners to safeguard the integrity of the global financial system," Mr Al Sayegh said in a statement on Wednesday.
The outcome reflects the UAE's sustained and swift action and integrated national response to financial crime risks, said Hamid Al Zaabi, secretary general and vice chairman of the UAE National Anti-Money Laundering and Combatting Financing of Terrorism and Financing of Illegal Organisations Committee.
"The country has significantly enhanced its legal, regulatory and operational frameworks, including increased inter-agency co-operation and a sharp rise in enforcement outcomes," he said.
"These reforms were recognised by the FATF in February 2024, when it removed the UAE from its grey list — an important development that directly informed the Commission's decision, endorsed by today's vote."
Building on that momentum, the UAE engaged in sustained technical dialogue with EU institutions — particularly through the UAE-EU Strategic Dialogue — which reinforced co-operation on financial intelligence sharing, cross-border investigations and asset recovery.
These actions "addressed residual concerns" within the European Parliament and demonstrated the UAE's ongoing commitment to international AML/CFT standards, Mr Al Zaabi told The National.
Lucie Berger, EU ambassador to the UAE, said in a post on X: "A great day for EU-UAE relations and another major milestone in our deepening co-operation. Together, we continue to build a strategic partnership founded on trust, shared values, and a joint commitment to global security and prosperity."
The decision comes after the UAE and EU recently agreed to launch free-trade negotiations.
It's a political decision because it comes as the UAE and the EU are advancing discussions for a free-trade agreement, said Nicolas Michelon, managing partner of Alagan Partners, a Dubai corporate geopolitics consultancy.
'What the EU is happy with now had been in place in the UAE for quite some time already. This is the EU seeking to remove all hurdles at home to make sure there is no political opposition to a free-trade agreement with the UAE,' he said.
The UAE has made significant progress in combating money laundering and the financing of terrorism over the past few years, passing strict laws and issuing regulations to clamp down on financial crime.
In September last year, the UAE set out a nationwide action plan aimed at combating terrorism financing and money laundering. The 2024-27 National Strategy for Anti-Money Laundering, Countering the Financing of Terrorism and Proliferation Financing has 11 goals focused on risk-based compliance, effectiveness and sustainability.
The enhanced framework, overseen by the Higher Committee and led by an expanded National Committee, includes the former Executive Office of Anti-Money Laundering and Counter Terrorism Financing, which now serves as the General Secretariat.
In August, the government also amended its laws against money laundering and the financing of terrorism and crime groups and formed a national committee on these crimes.
"For the UAE, immediate benefits of the delisting include reduced compliance friction for firms transacting with EU entities, and greater ease of access to European financial markets," Mr Al Zaabi said.
"Over the long term, the delisting reinforces the UAE's position as a leading international hub for finance and trade, supports its competitiveness, and strengthens its ability to contribute to and shape the development of global AML/CFT norms."
The UAE Central Bank has been imposing a growing number of fines and penalties in recent months to clamp down on violators.
On Monday, the banking regulator imposed a fine of Dh4.1 million ($1.1 million) on three exchange houses for failing to comply with the AML/CFT law.
Last week, it imposed a fine of Dh5.9 million on a branch of an unnamed foreign bank operating in the UAE for failing to comply with the AML/CFT framework and related regulations.
In June, the Central Bank imposed a Dh100 million fine on an exchange house for 'significant failures' in its AML/CFT framework. Also last month, the Central Bank suspended the Islamic window of a bank operating in the country from onboarding new customers for six months and fined it more than Dh3.5 million for non-compliance with Sharia governance rules.
This decision will reduce friction for UAE-based financial institutions in dealing with European counterparts, ease cross-border transactions and boost investor confidence in the jurisdiction's credibility, Dhruv Tanna, associate vice president at DIFC-based investment and wealth management firm Phillip Capital, told The National.
"This development will further support capital inflows, strategic partnerships and the growth of regulated sectors such as asset management, FinTech and private wealth services," he said.
Vijay Valecha, chief investment officer of Century Financial, said it will lead to reduced due diligence requirements for European institutions dealing with UAE-based companies. Previously, entities in the EU were mandated to apply enhanced scrutiny on transactions involving jurisdictions on the high-risk list. This often led to delays, increased paperwork and higher costs, he added.
The new move will "significantly benefit sectors like banking, FinTech, and trade finance, which rely on swift and seamless cross-border flows", he said.
When countries come off high-risk watchlists, they often see capital inflows of up to 7.6 per cent of their gross domestic product, with foreign direct investment alone increasing by around 3 per cent, according to the International Monetary Fund.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

European Union resigned to 15 percent US tariff
European Union resigned to 15 percent US tariff

Al Etihad

time16 minutes ago

  • Al Etihad

European Union resigned to 15 percent US tariff

28 July 2025 09:36 TURNBERRY (AFP)The United States and the European Union clinched a trade agreement on Sunday that will see EU exports taxed at 15 President Donald Trump emerged from a high-stakes meeting with European Commission President Ursula von der Leyen at his golf resort in Scotland, describing the deal as the "biggest-ever".The deal, which the leaders reached after an hour of talks, came as the clock ticked down on an August 1 deadline to avoid an across-the-board US levy of 30 percent on European goods."We've reached a deal. It's a good deal for everybody. This is probably the biggest deal ever reached in any capacity," said said a baseline tariff of 15 percent would apply across the board, including for Europe's crucial automobile sector, pharmaceuticals and part of the deal, Trump said the 27-nation EU bloc had agreed to purchase "$750 billion worth of energy" from the US, as well as make $600 billion in additional der Leyen said the "significant" purchases of US liquefied natural gas, oil and nuclear fuels would come over three years, as part of the bloc's bid to diversify away from Russian on behalf of the EU's 27 countries, von der Leyen had been pushing hard to salvage a trading relationship worth an annual $1.9 trillion in goods and services."It's a good deal," the EU chief told reporters."It will bring stability. It will bring predictability. That's very important for our businesses on both sides of the Atlantic," she added that bilateral tariff exemptions had been agreed on a number of "strategic products", notably aircraft, certain chemicals, some agricultural products and critical raw der Leyen said the EU still hoped to secure further so-called "zero-for-zero" agreements, which she hoped to be "sorted out" in the coming also said EU countries -- which recently pledged to ramp up their defence spending within NATO -- would be purchasing "hundreds of billions of dollars worth of military equipment."The EU is currently subject to a 25-percent levy on cars, 50 percent on steel and aluminium, and an across-the-board tariff of 10 new deal will need to be approved by EU member states -- whose ambassadors, on a visit to Greenland, were updated by the commission Sunday morning. They were set to meet again after the deal struck in Chancellor Friedrich Merz rapidly hailed the deal, saying it avoided "needless escalation in transatlantic trade relations".Ireland, one of the EU's top exporters to the US, said Sunday it welcomed the deal for bringing "a measure of much-needed certainty", but that it "regrets" the baseline tariff, in a statement by its Department of Foreign Affairs and minister for Europe, Benjamin Haddad, wrote on X on Monday that the agreement would provide "temporary stability... but it is unbalanced". While 15 percent is much higher than pre-existing US tariffs on European goods, which average around 4.8 percent, it mirrors the status quo, with companies currently facing an additional flat rate of 10 percent.

Minapharm's majority shareholder Triquera raises capital through minority stake investment from Admaius Capital Partners
Minapharm's majority shareholder Triquera raises capital through minority stake investment from Admaius Capital Partners

Zawya

time16 minutes ago

  • Zawya

Minapharm's majority shareholder Triquera raises capital through minority stake investment from Admaius Capital Partners

Cairo, Egypt - Admaius Capital Partners ('Admaius'), an Africa-focused private equity investor, and Triquera B.V. ('Triquera'), the majority shareholder in Minapharm Pharmaceuticals and Chemical Industries S.A.E. ('Minapharm'), a leading biopharmaceutical company in the Middle East and Africa and a global provider of proprietary technologies to leading biopharma players, today announced a strategic partnership following Admaius' investment in Triquera B.V. For over two decades, Minapharm has established a robust biopharmaceutical platform that combines world-class R&D with end-to-end manufacturing capabilities for complex genetically engineered therapeutic recombinant proteins and viral vectors as well as small molecules with advanced galenic formulations, operating across facilities in Cairo and Berlin. Today, Minapharm operates the largest biological drug substance and drug product facilities in the Middle East and Africa. Through its international subsidiaries, Minapharm licenses out proprietary technologies in the fields of monoclonal antibodies, vaccines, and cell and gene therapies. These technologies enable the development and production of advanced biologics that address critical unmet medical needs globally and have been incorporated into FDA-approved products, underscoring their clinical relevance and global impact. Together, Triquera and Admaius will focus on accelerating the development and production of complex genetically engineered therapies, while expanding access to high-quality, affordable recombinant proteins by investing in innovation and scaling distribution to better serve patients across underserved markets in Africa and the Middle East. In parallel, the partnership will pursue strategic acquisitions of global contract development and manufacturing organizations (CDMOs) to support Minapharm's growth in the biotech sector. This partnership reflects a shared commitment to advancing healthcare equity through innovation and aligns closely with Admaius' broader strategy of supporting mission-driven businesses and management teams in high-impact sectors across the African continent. Zilla Capital acted as the sole financial advisor to Triquera B.V. and the existing shareholders. Matouk Bassiouny served as legal counsel to Triquera B.V. and the existing shareholders. Admaius Capital Partners was advised by White and Case LLP as legal counsel and by Arthur D. Little as commercial advisor. Commenting on the investment: Dr. Wafik Bardissi, Chairman and CEO of Minapharm, said: "This partnership reflects the accelerating momentum of Minapharm's growth as we extend our leadership in biotherapeutics, cell and gene therapies, and proprietary platform technologies. With Admaius, we gain not only capital but a strategic partner whose insight, alignment, and ambition match our own. Together, we are advancing regional self-sufficiency and expanding the global reach of our innovations." Marlon Chigwende, Managing Partner of Admaius, said: 'This is a landmark transaction. The founding families have built a unique asset on the African and European continents that combines scale, growth and impact to fight cancer and other awful diseases. We are pleased to be able to partner with Triquera, Dr. Wafik and Dr. Shaheer and will help to internationalize and grow the business further.' Ahmed Rady, Managing Director of Admaius, said: 'At Admaius, we back exceptional management teams—and the team behind Minapharm is as impressive as the science, technology, and capabilities they've built across Cairo and Berlin. This partnership is about scaling a homegrown champion that combines cutting-edge global know-how with end-to-end manufacturing excellence. We're excited to support Minapharm in taking this next big step and look forward to working closely with the management team.' Dr. Shaheer Bardissi, Co-CEO of Minapharm, added: 'This strategic collaboration with Admaius will accelerate and scale Minapharm's vision of translating cutting-edge scientific innovation into affordable therapies, while advancing global scientific frontiers in immunotherapy as well as advanced therapy medicinal products, for the benefit of the broader biopharmaceutical industry.' Contacts For more information, please contact: Minapharm Christina Azmy cazmy@ (+2) (02) 24143170 Admaius Hannah Gilkes Phone number: +44 7515 958912

Saudi's Canadian Medical Center seeks Tadawul transition
Saudi's Canadian Medical Center seeks Tadawul transition

Zawya

time16 minutes ago

  • Zawya

Saudi's Canadian Medical Center seeks Tadawul transition

Saudi Arabia-based Canadian Medical Center Co. (CMC) has sought the approval from regulatory authorities to transition to the main market of Tadawul (Saudi Exchange). CMC shares debuted on the Saudi parallel market Nomu in August 2021. This past year, CMC has signed contracts with several projects backed by the $1.5 trillion Saudi sovereign investor, the Public Investment Fund, including a 93.67-riyal ($25 million) contract in May with the Saudi Arabian Mining Company (Ma'aden). (Writing by Bindu Rai, editing by Seban Scaria)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store